Preete Kerry J

SEC source: 0000899243-18-015522 · doc4.xml · derivative · entry 10

Preete Kerry J · CIK 0001438256 · EVP, Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,366 shares

Expires not disclosed

F1 · derivative.exercise_price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · derivative.exercise_price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

F1 · derivative.exercise_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · derivative.exercise_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

F1 · derivative.expiration_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · derivative.expiration_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

SEC source: 0000899243-18-015522 · doc4.xml · derivative · entry 9

Preete Kerry J · CIK 0001438256 · EVP, Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 390 shares

Expires not disclosed

F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

SEC source: 0000899243-18-015522 · doc4.xml · derivative · entry 8

Preete Kerry J · CIK 0001438256 · EVP, Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,350 shares

Expires not disclosed

F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

SEC source: 0000899243-18-015522 · doc4.xml · derivative · entry 7

Preete Kerry J · CIK 0001438256 · EVP, Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,290 shares

Expires not disclosed

F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

SEC source: 0000899243-18-015522 · doc4.xml · derivative · entry 6

Preete Kerry J · CIK 0001438256 · EVP, Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,390 shares

Expires not disclosed

F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

SEC source: 0000899243-18-015522 · doc4.xml · derivative · entry 5

Preete Kerry J · CIK 0001438256 · EVP, Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,560 shares

Expires not disclosed

F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.

SEC source: 0000899243-18-015522 · doc4.xml · nonDerivative · entry 4

Preete Kerry J · CIK 0001438256 · EVP, Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F5 · shares: Represents performance-based restricted stock units.

F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

SEC source: 0000899243-18-015522 · doc4.xml · nonDerivative · entry 3

Preete Kerry J · CIK 0001438256 · EVP, Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F4 · shares: Represents restricted stock units.

F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

SEC source: 0000899243-18-015522 · doc4.xml · nonDerivative · entry 2

Preete Kerry J · CIK 0001438256 · EVP, Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401(k) Plan

Disclosed balance after: 0

F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

SEC source: 0000899243-18-015522 · doc4.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · EVP, Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").

F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.

SEC source: 0001225208-18-010486 · doc4.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83

F1 · shares: Prorated annual director grant that vested in full on June 7, 2018.

SEC source: 0001225208-18-009174 · doc4.xml · derivative · entry 1

Preete Kerry J · CIK 0001438256 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,241

Underlying: Common Stock · 4,241 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") is equivalent to one share of common stock upon vesting.

F2 · derivative.exercise_date: The Reporting Person has recevied an award of Defferred Stock Units ("DSUs") under the Company's 2017 Omnibus Equity Incentive Plan (the "Plan"). The DSUs become vested on the one year anniversary of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in contol as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code.

F2 · derivative.expiration_date: The Reporting Person has recevied an award of Defferred Stock Units ("DSUs") under the Company's 2017 Omnibus Equity Incentive Plan (the "Plan"). The DSUs become vested on the one year anniversary of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in contol as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code.

SEC source: 0001127602-18-013800 · form4.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Comp Plan

Disclosed balance after: 13,444

F1 · balance_after: Includes 46 shares acquired on January 10, 2018 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001127602-18-000187 · form4.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Comp Plan

Disclosed balance after: 12,721

F1 · balance_after: Includes 36 shares acquired on October 5, 2017 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001110783-17-000274 · edgar.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,969

F1 · shares: On November 15, 2017, 2,120 time-based restricted stock units became fully vested for which taxes became due and payable. 967 restricted stock units were used for the payment of these taxes.

SEC source: 0001110783-17-000217 · edgar.xml · nonDerivative · entry 2

Preete Kerry J · CIK 0001438256 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,935

F2 · shares: Restricted stock unit grant pursuant to the Monsanto Company 2005 Long-Term Incentive Plan, vesting one-third on November 15, 2018, one-third on November 15, 2019 and the remaining one-third on November 15, 2020.

SEC source: 0001110783-17-000217 · edgar.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,936

F1 · shares: Restricted stock unit grant pursuant to the Monsanto Company 2005 Long-Term Incentive Plan, vesting on November 15, 2017.

SEC source: 0001110783-17-000273 · edgar.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,936

F1 · balance_after: On October 30, 2017, the Company mistakenly filed a Form 4 on the reporting person's behalf reporting the grant of 6,999 restricted stock units vesting on November 15, 2017 as an acquisition of common stock that did not occur. This amended Form 4 is being filed to reflect the deletion of such transaction. The remaining transaction(s) contained in such Form 4 are not amended hereby.

SEC source: 0001127602-17-028644 · form4.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Comp Plan

Disclosed balance after: 12,029

F1 · balance_after: Includes 36 shares acquired on July 7, 2017 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001127602-17-022986 · form4.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Comp Plan

Disclosed balance after: 11,279

F1 · balance_after: Includes 38 shares acquired on April 6, 2017 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001110783-17-000177 · edgar.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,937

SEC source: 0001110783-17-000078 · edgar.xml · nonDerivative · entry 2

Preete Kerry J · CIK 0001438256 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,912

F2 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 14, 2016.

F3 · price: This price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $116.78 to $116.98. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.

SEC source: 0001110783-17-000078 · edgar.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,258

F1 · shares: On May 1, 2017 restricted stock units became fully vested for which taxes became due and payable. 8,053 restricted stock units were used for the payment of these taxes.

SEC source: 0001127602-17-013906 · form4.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Comp Plan

Disclosed balance after: 10,501

F1 · balance_after: Includes 35 shares acquired on January 6, 2017 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001127602-17-000260 · form4.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Comp Plan

Disclosed balance after: 9,624

SEC source: 0001110783-16-000601 · edgar.xml · nonDerivative · entry 2

Preete Kerry J · CIK 0001438256 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,311

F2 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2016.

SEC source: 0001110783-16-000601 · edgar.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,056

F1 · shares: On November 15, 2016, 4,120 performance-based restricted stock units became fully vested for which taxes became due and payable. 1,375 restricted stock units were used for the payment of these taxes.

SEC source: 0001110783-16-000545 · edgar.xml · nonDerivative · entry 3

Preete Kerry J · CIK 0001438256 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,431

F2 · shares: Restricted stock unit grant pursuant to the Monsanto Company 2005 Long-Term Incentive Plan, vesting one-third on November 15, 2017, one-third on November 15, 2018 and the remaining one-third on November 15, 2019.

SEC source: 0001110783-16-000545 · edgar.xml · nonDerivative · entry 2

Preete Kerry J · CIK 0001438256 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,069

F1 · shares: Restricted stock unit grant pursuant to the Monsanto Company 2005 Long-Term Incentive Plan, vesting on November 15, 2016.

SEC source: 0001127602-16-063721 · form4.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Comp Plan

Disclosed balance after: 8,707

F1 · balance_after: Includes 23 shares acquired on July 8, 2016 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001110783-16-000545 · edgar.xml · nonDerivative · entry 1

Preete Kerry J · CIK 0001438256 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,949